2021-08-29 18:01Press release

Cell culturing to be developed with Sten K Johnson Foundation grant

Roger Rönn, CEO of Sorbus BiomedicalRoger Rönn, CEO of Sorbus Biomedical

Roger Rönn, CEO of Sorbus Biomedical, has received a grant from the Sten K Johnson Foundation for the company’s project “Equipment for culturing cells with increased function and application potential.” The grant is vital for the company’s continued development of a discovery that could result in a paradigm shift in the field of cell culture. Sorbus Biomedical is a member of SmiLe Incubator.

Roger Rönn made the discovery during his research career, and he is now developing an instrument that will produce cultured cells of higher quality than those produced using current cell culturing methods.

Cultured cells have many applications; for example, they are used in the production of proteins for research and pharmaceuticals, as well as for cell transplantation in the treatment of various diseases. With support from the Sten K Johnson Foundation, Roger Rönn can achieve an important milestone: to identify areas in which his innovation can have the greatest impact and to prioritize those areas of application that have the greatest potential and commercial value.

“The grant from Sten K Johnson will allow me to work on this full-time over the next twelve months. My goal is to use the business advice, support and lab equipment available at SmiLe to select the applications that are most beneficial to the company’s development,” says Roger Rönn.

The opportunities for innovation are many, and he plans to expand in pace with the development of appropriate equipment.

“I am extremely grateful and happy about receiving support from Sten K Johnson, and I am highly motivated. Thanks to these resources, I can now make progress with the development of the company as I had hoped. It’s still early in the journey, but it feels great to be at SmiLe. I appreciate everyone’s involvement and drive, and it feels like a fantastic environment with great opportunities for the company to grow,” says Roger Rönn.


For more information, please contact: Roger Rönn, CEO of Sorbus Biomedical, +46 (0)73 5366181, roger.ronn@sorbusbiomedical.se


Language: English

About SmiLe Venture Hub – Pioneering Life Science Innovations

SmiLe Incubator is a life science business incubator based in Medicon Village in Lund, Sweden. SmiLe helps entrepreneurs commercialize their ideas. There are currently 25 companies in SmiLe which, together with alumni companies, have attracted more than EUR 460 million in venture capital to date since 2014. SmiLe offers excellent business coaching, a broad international network of contacts and a dynamic community, as well as well-equipped laboratories which is unique of its kind in Sweden. SmiLe is a non-profit organization and receives basic funding from Region Skåne, Lund Municipality, Lund University and Medicon Village. SmiLe´s sponsors are Agilent, Sparbanken Skåne, Awa, Høiberg, Prevas, Setterwalls, Zacco, Aqilion. SmiLe’s listed alumni companies have a market capitalization of EUR 1,3 billion (Q1 2021). www.smileincubator.life